Effects of Tumor Necrosis Factor and Interferon on Breast Cancer in Rats
Author Information
Author(s): P. Shah, P.H. van der Meide, T. Borman, N. Schroeder, J.M. Bliss, R.C. Coombes
Primary Institution: Ludwig Institute for Cancer Research
Hypothesis
Can combined treatment with human recombinant tumor necrosis factor and rat gamma interferon induce tumor regression in a rat mammary tumor model?
Conclusion
Combined therapy with human recombinant tumor necrosis factor and rat gamma interferon may be a useful new treatment for human breast cancer.
Supporting Evidence
- Combined treatment with rHu-TNF and rat IFN-y induced significant tumor regression.
- Treatment with either rHu-TNF or rat IFN-y alone did not significantly affect tumor growth.
- Initial reduction in tumor size was observed after treatment, but growth resumed after a few days.
Takeaway
Researchers tested two drugs on rats with breast tumors and found that using both together helped shrink the tumors better than using either one alone.
Methodology
The study used an inbred strain of tumor-bearing female rats, which were randomized into treatment and control groups, and monitored tumor size over a 28-day period.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Inbred virgin female Ludwig/Wistar/Olac rats
Statistical Information
P-Value
0.004
Confidence Interval
95%
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website